Blockade of deubiquitinating enzyme PSMD14 overcomes chemoresistance in head and neck squamous cell carcinoma by antagonizing E2F1/Akt/SOX2-mediated stemness
Authors:
Open Access
- 1 January 2021
- journal article
- research article
- Published by Ivyspring International Publisher in Theranostics
- Vol. 11 (6) , 2655-2669
Abstract
Increasing evidence reveals a close relationship between deubiquitinating enzymes (DUBs) and cancer progression. In this study, we attempted to identify the roles and mechanisms of critical DUBs in head and neck squamous cell carcinoma (HNSCC).Keywords
This publication has 57 references indexed in Scilit:
- Molecular mechanisms of cisplatin resistanceOncogene, 2011
- Hypoxia-mediated drug resistance: Novel insights on the functional interaction of HIFs and cell death pathwaysDrug Resistance Updates, 2011
- Co‐overexpression of p21 and Ki‐67 in head and neck squamous cell carcinoma relative to a significantly poor prognosisHead & Neck, 2011
- Deubiquitinase USP9X stabilizes MCL1 and promotes tumour cell survivalNature, 2009
- Thiolutin inhibits endothelial cell adhesion by perturbing Hsp27 interactions with components of the actin and intermediate filament cytoskeletonCell Stress and Chaperones, 2009
- Mutations of multiple genes cause deregulation of NF-κB in diffuse large B-cell lymphomaNature, 2009
- Platinum Resistance: The Role of DNA Repair PathwaysClinical Cancer Research, 2008
- Determination of mRNA half-lives inCandida albicansusing thiolutin as a transcription inhibitorGenome, 2006
- Bortezomib or High-Dose Dexamethasone for Relapsed Multiple MyelomaNew England Journal of Medicine, 2005
- JAMM: A Metalloprotease-Like Zinc Site in the Proteasome and SignalosomePLOS Biology, 2003